Denmark‘s economy is heading for slower growth as the pharmaceutical boom led by Novo Nordisk A/S loses steam and the industry settles into a pace more in line with the rest of the economy, the country’s financial watchdog said.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.